Get the Stockscreener App
2.6975
2.55%
-0.0425
Acurx Pharmaceuticals Inc stock is traded at $2.6975, with a volume of 10,125.
It is down -2.55% in the last 24 hours and down -16.30% over the past month.
Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration. The company's approach is to develop antibiotic candidates with a Gram-positive selective spectrum. The Company's segment consists of the development of clinical and preclinical product candidates for the development of the Company's proprietary new therapies.
See More
Previous Close:
$2.74
Open:
$2.71
24h Volume:
10,125
Relative Volume:
0.15
Market Cap:
$6.27M
Revenue:
-
Net Income/Loss:
$-14.58M
P/E Ratio:
-2.3457
EPS:
-1.15
Net Cash Flow:
$-9.80M
1W Performance:
+4.71%
1M Performance:
-16.30%
6M Performance:
-67.11%
1Y Performance:
-84.11%
1-Day Range:
$2.67
$2.8394
1-Week Range:
$2.51
$2.89
52-Week Range:
$2.44
$21.00
Acurx Pharmaceuticals Inc Stock (ACXP) Company Profile
Name
Acurx Pharmaceuticals Inc
Sector
Industry
Phone
917-533-1469
Address
259 LIBERTY AVENUE, STATEN ISLAND
Compare ACXP with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ACXP
Acurx Pharmaceuticals Inc
|
2.67 | 6.43M | 0 | -14.58M | -9.80M | -1.15 |
|
VRTX
Vertex Pharmaceuticals Inc
|
481.18 | 120.98B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
765.33 | 80.15B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
868.53 | 51.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
361.43 | 47.74B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
336.25 | 37.38B | 4.98B | 69.59M | 525.67M | 0.5197 |
Acurx Pharmaceuticals Inc Stock (ACXP) Latest News
Street Watch: Is Acurx Pharmaceuticals Inc stock undervalued right now2025 Price Momentum & Daily Oversold Bounce Ideas - baoquankhu1.vn
Loss-Making Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) Expected To Breakeven In The Medium-Term - Yahoo Finance
Will Acurx Pharmaceuticals Inc. stock remain a Wall Street favoriteVolatility Trading Techniques & Small Budget Trading Ideas - bollywoodhelpline.com
Why Acurx Pharmaceuticals Inc. stock is in analyst buy zoneMarket Sentiment Indicators & Double Digit Profit Strategies - bollywoodhelpline.com
Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) Sees Significant Decrease in Short Interest - Defense World
Portfolio Recap: Is DHCNI stock suitable for long term investingQuarterly Earnings Report & Weekly Market Pulse Alerts - baoquankhu1.vn
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
Bank Watch: What is the dividend yield of Acurx Pharmaceuticals IncRate Hike & Expert Approved Momentum Trade Ideas - baoquankhu1.vn
What is RLYBs valuation compared to sectorMarket Sentiment Review & Smart Allocation Stock Reports - baoquankhu1.vn
Growth Review: Can VSTEW sustain its profitabilityTrade Exit Summary & AI Based Trade Execution Alerts - baoquankhu1.vn
Stock Analysis: Can Acurx Pharmaceuticals Inc disrupt its industryPortfolio Update Report & Safe Capital Growth Trade Ideas - baoquankhu1.vn
Is Acurx Pharmaceuticals Inc. stock positioned for long term growthDurability and Wear Notes & simple selection tips for new buyers - Улправда
Quarterly Trades: How strong is Acurx Pharmaceuticals Inc. stock balance sheetWeekly Stock Analysis & Consistent Return Investment Signals - Улправда
How strong is Acurx Pharmaceuticals Inc. stock balance sheetCEO Change & Smart Money Movement Tracker - Улправда
Sentiment Watch: Will Acurx Pharmaceuticals Inc. stock remain a Wall Street favoriteQuarterly Profit Report & Smart Swing Trading Alerts - Улправда
Aug Shorts: Can Acurx Pharmaceuticals Inc. stock beat analyst upgradesJuly 2025 WrapUp & Verified Entry Point Signals - Улправда
Has Acurx Pharmaceuticals (ACXP) Outpaced Other Medical Stocks This Year? - Yahoo Finance
Acurx Pharmaceuticals Inc 3ZO Stock Analysis and ForecastMerger & Acquisition Updates & Plan Your Future With Strategic Investing - earlytimes.in
Risk Off: Can Acurx Pharmaceuticals Inc stock beat analyst upgradesMarket Volume Summary & Risk Controlled Daily Trade Plans - Bộ Nội Vụ
Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) Resigns with New to The Street for Long-Form Interviews, National TV Commercials, Earned Media, and Accredited Investor Events - Greenville Online
Aug EndMonth: Why Acurx Pharmaceuticals Inc stock is in analyst buy zone2025 Market Sentiment & Free Expert Approved Momentum Trade Ideas - moha.gov.vn
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
Acurx Pharmaceuticals (ACXP) Stock Analysis Report | Financials & Insights - Benzinga
Acurx Pharmaceuticals (NASDAQ:ACXP) Upgraded to “Hold” at Wall Street Zen - Defense World
Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) Sees Significant Growth in Short Interest - Defense World
Exide Industries Limited Flashes Buy Signal on Multi Timeframe ChartStock Watchlist Updates & High Return Wealth Building - earlytimes.in
What drives Acurx Pharmaceuticals Inc stock priceTechnical Breakout Signals & We Spotted the Next Tesla – See Inside - earlytimes.in
Acurx Pharmaceuticals (NASDAQ:ACXP) Downgraded by Wall Street Zen to Sell - Defense World
Why Acurx Pharmaceuticals Inc. stock remains undervaluedEarnings Risk Summary & Low Drawdown Trading Techniques - DonanımHaber
How Acurx Pharmaceuticals Inc. stock compares to growth peersLong Setup & Real-Time Market Sentiment Reports - DonanımHaber
Why Acurx Pharmaceuticals Inc. (3ZO) stock could break out in 2025July 2025 Selloffs & Accurate Intraday Trading Signals - Улправда
Aug Outlook: Can Acurx Pharmaceuticals Inc stock beat analyst upgradesShare Buyback & Weekly Stock Performance Updates - Bộ Nội Vụ
Market Review: Why Acurx Pharmaceuticals Inc. (3ZO) stock could break out in 2025Earnings Overview Summary & Expert Verified Movement Alerts - Улправда
Acurx Pharmaceuticals Earnings Notes - Trefis
Acurx Pharmaceuticals (NASDAQ:ACXP) Shares Down 9.3% – Time to Sell? - Defense World
Will Acurx Pharmaceuticals Inc. (3ZO) stock beat growth indexes2025 Volatility Report & Real-Time Market Trend Scan - Newser
Will Acurx Pharmaceuticals Inc. (3ZO) stock draw ESG focused fundsWeekly Trend Summary & AI Based Trade Execution Alerts - Newser
Will Acurx Pharmaceuticals Inc. (3ZO) stock justify high valuation2025 Stock Rankings & Weekly Breakout Stock Alerts - Newser
Is Acurx Pharmaceuticals Inc. stock a defensive play in 2025Entry Point & Verified Short-Term Plans - Newser
Will Acurx Pharmaceuticals Inc. (3ZO) stock beat Nasdaq index returns - Newser
Perhaps timely catching Acurx Pharmaceuticals Inc (ACXP) would be a good idea - Setenews
Wall Street Zen Upgrades Acurx Pharmaceuticals (NASDAQ:ACXP) to Hold - Defense World
Acurx Pharmaceuticals Inc. (ACXP) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Why Acurx Pharmaceuticals Inc. (3ZO) stock is upgraded to buy2025 Bull vs Bear & Free Long-Term Investment Growth Plans - newser.com
Is Acurx Pharmaceuticals Inc. (3ZO) stock a defensive play amid uncertaintyInsider Buying & Weekly Market Pulse Alerts - newser.com
Will Acurx Pharmaceuticals Inc. stock benefit from green energy trendsPortfolio Gains Report & Step-by-Step Trade Execution Guides - newser.com
Can Acurx Pharmaceuticals Inc. (3ZO) stock withstand sector downturnsJuly 2025 Fed Impact & Daily Growth Stock Tips - newser.com
What is the fair value of Acurx Pharmaceuticals Inc. stock nowTrade Exit Summary & Long Hold Capital Preservation Tips - newser.com
Acurx Pharmaceuticals Inc Stock (ACXP) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.34%
0.37%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):